Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

• প্রধান লেখক: Zufit Hexner-Erlichman (লেখক), Maria Veiga- (লেখক), Yoav Zehavi (লেখক), Zahava Vadasz (লেখক), Adi D. Sabag (লেখক), Sameh Tatour (লেখক), Ronen Spiegel (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

BackgroundGlycogen storage disease type 1b (GSD1b) is an ultra-rare autosomal recessive disorder, caused by mutations in SLC37A4 gene. Affected patients present with episodes of fasting hypoglycemia and lactic acidosis, hepatomegaly, growth retardation, hyperlipidemia and renal impairment. In additi...